PRTN3 and arthritic joint disease: Serum levels were found to be increased in two independent cohorts of ACPA-positive symptomatic at-risk patients as compared with healthy as well as ACPA-negative arthralgia patients and were prognostic for arthritis onset in one of the cohorts.88